Skip to results
Modify your search
NARROW
1-4 of 4
Authors: Federico Cappuzzo
Sort by
Journal Article
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials
Lee X Li and others
The Oncologist, Volume 28, Issue 4, April 2023, Pages e205–e211, https://doi.org/10.1093/oncolo/oyad043
Published: 11 March 2023
Journal Article
Italian Cohort of Nivolumab Expanded Access Program in Squamous Non‐Small Cell Lung Cancer: Results from a Real‐World Population
Lucio Crinò and others
The Oncologist, Volume 24, Issue 11, November 2019, Pages e1165–e1171, https://doi.org/10.1634/theoncologist.2018-0737
Published: 17 April 2019
Journal Article
Future Scenarios for the Treatment of Advanced Non-Small Cell Lung Cancer: Focus on Taxane-Containing Regimens
Francesco Grossi and others
The Oncologist, Volume 15, Issue 10, October 2010, Pages 1102–1112, https://doi.org/10.1634/theoncologist.2010-0322
Published: 07 October 2010
Journal Article
Understanding the New Genetics of Responsiveness to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
Luca Toschi and Federico Cappuzzo
The Oncologist, Volume 12, Issue 2, February 2007, Pages 211–220, https://doi.org/10.1634/theoncologist.12-2-211
Published: 01 February 2007
Advertisement
Advertisement